Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLetter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy?AuthorsLiao, Y.‐Y.; Ahir, B.‐K.; Mo, H.‐Y.; Li, L.‐Q.; Peng, N.‐F.AbstractA letter to the editor is presented in response to the study regarding the efficacy of oral nucleos(t)ide analogue therapy in patients with hepatitis B virus-related hepatocellular carcinoma (HCC) by G. L. Wong and colleagues in the 2016 issue.SubjectsANTIVIRAL nucleosides; HEPATITIS B treatment; LIVER cancerPublicationAlimentary Pharmacology & Therapeutics, 2016, Vol 44, Issue 8, p908ISSN0269-2813Publication typeArticleDOI10.1111/apt.13773